Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of tofacitinib in digestive organ disease (Japan)
jRCT2080221983Phase 2Completed
- Start
- Dec 2012
- Modality
- Small Molecules
01
Overview
Phase 2 trial of tofacitinib in gastrointestinal conditions. Started Dec 2012; status: completed.
02
Drugs
03
Conditions
gastrointestinal conditions
Beyond the preview
Go deeper on jRCT2080221983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221983.